Parasite density and serum cytokine levels in Plasmodium vivax malaria in Turkey. (Q40480778)

20 September 2017

Parasite density and serum cytokine levels in Plasmodium vivax malaria in Turkey. (English)

1 reference

20 September 2017

0 references

0 references

Plasmodium vivax malaria

1 reference

F Yildiz Zeyrek

1

1 reference

20 September 2017

M A Kurcer

series ordinal

2

1 reference

20 September 2017

D Zeyrek

series ordinal

3

1 reference

20 September 2017

Z Simsek

series ordinal

4

1 reference

20 September 2017

language of work or name

1 reference

1 May 2006

1 reference

20 September 2017

1 reference

20 September 2017

28

1 reference

20 September 2017

5

1 reference

20 September 2017

201-207

1 reference

The immune response to Plasmodium falciparum malaria.

20 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00822.X

Plasma levels of interleukin-18 and interleukin-12 in Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00822.X

The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00822.X

Interleukin-10 inhibits tumor necrosis factor production but not antigen-specific lymphoproliferation in acute Plasmodium falciparum malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00822.X

Plasma levels of the interleukin-6 cytokine family in persons with severe Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00822.X

Cytokines and malaria parasitemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00822.X

Efficacy of chloroquine in the treatment of Plasmodium vivax malaria in Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00822.X

Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy con

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00822.X

Sterile protection of monkeys against malaria after administration of interleukin-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00822.X

Increased levels of interleukin-12 in Plasmodium falciparum malaria: correlation with the severity of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00822.X

Reduced interleukin-12 and transforming growth factor-beta1 in severe childhood malaria: relationship of cytokine balance with disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00822.X

Endogenous interleukin-10 modulates proinflammatory response in Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00822.X

Low plasma concentrations of interleukin-10 in severe malarial anaemia compared with cerebral and uncomplicated malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00822.X

Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00822.X

IL-10, an inflammatory/inhibitory cytokine, but not always.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00822.X

Interleukin-8 and Plasmodium falciparum malaria in Thailand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00822.X

Putative pathophysiological interactions of cytokines and phagocytic cells in severe human falciparum malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00822.X

TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00822.X

Serum cytokine profiles in patients with Plasmodium vivax malaria: a comparison between those who presented with and without hepatic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00822.X

Serum concentrations of MIP-1 alpha and interleukin-8 in patients suffering from acute Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00822.X

Plasma and in vitro levels of cytokines during and after a Plasmodium falciparum malaria attack in Gabon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00822.X

Cytokine expression in the brain in human cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00822.X

The paroxysm of Plasmodium vivax malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00822.X

Role of proinflammatory and anti-inflammatory cytokines in the immune response to Plasmodium falciparum malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00822.X

Human cytokine responses to meso-endemic malaria on the Pacific Coast of Colombia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3024.2006.00822.X

10.1111/J.1365-3024.2006.00822.X

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference